PRF Therapy for Pocket Reduction

Periodontitis Clinical Trial

Official title:

Comparative Evaluation of Clinical Parameters in Early-Stage III Grade A Periodontitis Patients After Insertion of Platelet Rich Fibrin as Step 2 Phase I Therapy in Periodontal Pockets: A Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05908929
• Other study ID #: 2022/2023
• Status: Completed
• Phase: N/A
• Start date: September 15, 2022
• Est. completion date: February 15, 2023

Study information

• Verified date: June 2023
• Source: Federico II University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Periodontal regenerative therapy has focused on various non-surgical and surgical treatment methods. Platelet-rich fibrin (PRF) has shown to possess multiple uses, including properties that promote healing of both soft and hard tissues. In the present study, we hypothesized that the addition of PRF into periodontal pockets, as an adjunct to conventional scaling and root planing (SRP), would enhance the outcomes of non-surgical periodontal therapy. This split-mouth randomized controlled clinical trial included 26 periodontal pocket sites in 13 patients with periodontitis. The pockets were randomly assigned as either test or control sites. In the test group, PRF was placed as an adjunct to SRP, while the control group received SRP alone. Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured at baseline and at six weeks. The wound healing index was measured during the six-week follow-up period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13
• Est. completion date: February 15, 2023
• Est. primary completion date: January 15, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• either gender,
• aged 18 years or older,
• patients without a medical history of systemic diseases,
• patient with chronic periodontitis
• patient with 5 or 6 mm of probing depth

Exclusion Criteria:

• patients with medical history of systemic disease or bleeding disorders
• presence of other gingival diseases (such as leukoplakia, lichen planus, pemphigoid disorders, pemphigus vulgaris, herpetic lesions, Necrotizing Ulcerative Periodontitis (NUP)
• pregnancy
• history of any drug usage affecting the periodontium for the past six months (such as systemic antibiotic therapy)
• previous periodontal treatment in the last six months
• smoking
• teeth with untreated caries
• endodontic lesions and grade II or more mobility
• subjects with acute exacerbation of periodontitis
• patients with systemic
• disease or condition that could affect tissue healing (e.g., autoimmune disease)
• severe furcation involvement (grade II and III)
• abutment for prosthetic rehabilitation
• active orthodontic therapy

Related Conditions & MeSH terms

• Periodontal Pocket
• Periodontitis

Intervention

Procedure:
• SRP and concomitant insertion of PRF membrane
The pockets were treated with scaling and root planing (SRP) along with the simultaneous insertion of a Platelet Rich Fibrin (PRF) membrane. Blood samples were drawn without anticoagulants in 10 mL tubes, which were immediately centrifuged at 4000 rpm for 8 minutes. Upon centrifugation, the blood showed three distinct layers: the uppermost layer contained platelet poor plasma, the middle layer consisted of a fibrin clot, and the lowermost band appeared bright red due to the presence of red blood cells. The fibrin clot polymerized in a diffuse manner within the tube, which was then cut with sharp scissors and squeezed between two glass slides to obtain a thick membrane. The PRF membrane was carefully handled using a carrier and isolated with a periodontal pack dressing (Coe-Pak). All patients were followed up at one week and six weeks after the treatment.
• SRP
The pockets were treated using the conventional procedure of scaling and root planing (SRP) utilizing curettes and an ultrasonic device. All patients were followed up at one week and six weeks after the treatment.

Locations

Country	Name	City	State
Italy	University of Naples Federico II	Naples
Italy	Università degli Studi di Napoli Federico II	Napoli

Sponsors (1)

Lead Sponsor	Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pocket depth	Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured	6 weeks